Azienda ospedaliera San Camillo-Forlanini

Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study (2022) Dey M, Naveen R, Nikiphorou E, Sen P, Saha S, Lilleker JB, Agarwal V, et al. Journal article, Letter Short-term Safety of COVID-19 Vaccination in Systemic Sclerosis Patients: Report from a Global Patient-Reported E-survey (2022) Thakare D, Naveen R, Pauling J, Ahmed S, Wincup C, Del Papa N, Sambataro G, et al. Conference contribution Breakthrough Infections in COVID-19 Vaccinated Patients with Systemic Sclerosis: A Survival Analysis from a Multicenter International Patient-Reported Survey (2022) Ahmed S, Naveen R, Pauling J, Thakare D, Wincup C, Del Papa N, Sambataro G, et al. Conference contribution Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies (2022) Cavagna L, Meloni F, Meyer A, Sambataro G, Belliato M, De Langhe E, Cavazzana I, et al. Journal article Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. (2022) Cavagna L, Meloni F, Meyer A, Sambataro G, Belliato M, De Langhe E, Cavazzana I, et al. Journal article Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT (2020) Schmidt-Hieber M, Engelhard D, Ullmann A, Ljungman P, Maertens J, Martino R, Rovira M, et al. Journal article Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: a report from the EBMT acute leukemia working party (2020) Bazarbachi A, Labopin M, Angelucci E, Gülbas Z, Ozdogu H, Arat M, De Rosa L, et al. Journal article Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course (2019) Cavagna L, Trallero-Araguas E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, et al. Journal article Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: Outcome strongly correlates with disease status; a report from the EBMT acute leukemia working party (2019) Bazarbachi A, Labopin M, Angelucci E, Gulbas Z, Ozdogu H, Arat M, De Rosa L, et al. Conference contribution Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease (2015) Monteleone G, Neurath M, Ardizzone S, Di Sabatino A, Fantini MC, Castiglione F, Scribano ML, et al. Journal article